Editorial: A summertime fable 2009 State of the Industry: New BrunswickExpanded scope takes hold 2009 State of the Industry Report: Where we are now Drugstore Canada’s annual snapshot of the pharmacy industry Piroxicam: indications restricted Piroxicam is no longer indicated for the treatment of acute pain or inflammation. BC docs set to work with pharmacists Aging trend in nursing has serious implications for nurse career longevity, study reports Surrey hospital report released Summarizes benefits of delivery as a PPP Simponi: new biologic for RA, psoriatic arthritis and ankylosing spondylitis Schering-Plough is introducing Simponi (golimumab), a new tumour necrosis factor (TNF) alpha inhibitor. Guidelines overturn 'automatic' C-sections SOGC advice for breech presentations Lyme disease: exposure risk increasing New evidence suggests that the risk of exposure to Lyme disease in eastern and central Canada in increasing. First Previous 1657 1658 1659 1660 1661 Next Last
